期刊文献+

sTRAIL及受体TRAIL-R1在DNT细胞抑制胰腺癌细胞中的作用及意义 被引量:8

Expression and significance of sTRAIL and TRAIL-R1 in inhibitory on pancreatic cancer cells by DNT cells
下载PDF
导出
摘要 目的探讨肿瘤坏死因子相关凋亡诱导配体(sTRAIL)与其受体TRAIL-R1在DNT细胞杀伤胰腺癌细胞中的作用及意义。方法采用抗体吸附法培养外周血中分离的DNT细胞,ELISA法检测其细胞培养上清液中的sTRAIL水平。采用qPCR、Western blot法检测TRAIL-R1在5株胰腺癌细胞株中的表达,免疫组织化学法检测48例胰腺癌组织标本中TRAIL-R1的表达情况,分析其与病理参数之间的关系。结果 DNT细胞数目逐渐增多,其培养液中sTRAIL与对照组相比浓度明显升高(t=17.24,P<0.05)。qPCR检测受体TRAIL-R1在5株胰腺癌细胞中均有表达,Western blot法检测TRAIL-R1受体表达发现在胰腺癌细胞系CFPAC-1中表达高,在MIA PaCa-2和panc-1中表达较高,BXPC-3中表达较低,在Capan-1细胞系中不表达。TRAIL-R1在胰腺癌组的阳性表达率及染色强度低于相应的癌旁组织(χ2=7.43、12.48,P<0.05);TRAIL-R1的表达与染色强度有关(χ2=12.48,P<0.05)。结论外周血来源的DNT细胞可分泌sTRAIL,sTRAIL与胰腺癌细胞和组织所表达的受体TRAIL-R1结合诱导细胞凋亡,可能是DNT细胞抑制胰腺癌细胞增殖的机制之一。 Objective To investigate the role and significance of the soluble tumor necrosis factor-related apoptosis- inducing ligand (sTRAIL) binding to its receptor TRAIL-R1 in DNT cell suppressing, Methods. DNT cells could be cultured according a novel of effective protocol of antibody adsorption, ELISA methods were used to measure the levels of sTRAIL in the culture supernatants. Real time RT-PCR, Western blot were employed to compare the ex- pression of TRAIL-R1 in 5 pancreatic cancer cell lines and the expression of TRAIL-R1 in 48 cases of pancreatic ductal adenocarcinoma tissues could be observed by immunohistochemistry, we evaluated the association of TRAIL- R1 with clinical pathological parameters. Results The number of cells gradually was improved and serum sTRAIL were higher in supernatants group than that in control group (t = 17.24 ,P 〈 0. 05 ). High level of TRAIL-R1 was detected in 5 pancreatic cancer cell lines from transcript. We found that the expression of TRAIL-R1 was highest in human pancreatic carcinoma CFPAC-1 cell line, higher in MIA PaCa-2 and pane-1 while low in BXPC-3 while do not express in Capan-1. Immunohistochemistry results indicated that the expression and stainingintensity of TRAIL- R1 were lower than carcinoma tissues ( χ2 = 7.43, P 〈 0. 05 ) and expression positively correlated with histological grade and T status ( χ2 = 12.48,P 〈 0. 05 ). Conclusion DNT ceils could secrete sTRAIL and it may be one of the mechanisms of DNT cells inhibiting the proliferation of human pancreatic cancer cells by sTRAIL bind to TRAIL-R1, which is expressed by pancreatic cancer cell lines and tissues, to induced cell apoptosis.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第11期1613-1617,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81071985) 安徽省国际科技合作项目(编号:10080703038)
关键词 胰腺癌 DNT细胞 TRAIL-R1 pancreatic cancer DNT cell TRAIL-R1
  • 相关文献

参考文献15

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [ J] CA Cancer J Clin, 2012,62( 1 ) :10 -29. 被引量:1
  • 2杨仁保,陈炯,卢寅,武文,周杭城,陈龙江,胡立威.DNT细胞的扩增及其对胰腺癌Panc-1细胞的影响[J].安徽医科大学学报,2013,48(3):228-232. 被引量:2
  • 3Jablonska E, Jablonski J, Marcinczyk M, et al. The release of sol- uble forms of TRAIL and DR5 by neutrophils of oral cavity cancer patients [ J]. Folia Histochem Cytobiol,2008,46 (2) : 177 - 83. 被引量:1
  • 4Tanaka H, ho T, Kyo T, et al. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients [ J ]. Eur J Haematol, 2007,78 (5) :389 - 98. 被引量:1
  • 5Sobin L H, Wittekind C. UICC-TNM classification of malignant tumours[ M]. 6th ed. New York: Wiley-Lissm,2002. 被引量:1
  • 6Merims S, Li X, Joe B, et al. Anti-leukemia effect of ex vivo ex- panded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy [ J ]. Leukemia, 2011,25 ( 9 ) : 1415 -22. 被引量:1
  • 7Dokouhaki P, Han M, Joe B, et al. Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells: A new approach [ J]. Cancer Lett,2010, 297 ( 1 ) : 126 - 36. 被引量:1
  • 8Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 ( - Delta Delta C (T)) method [J]. Methods,2001, 25(4) :402 -8. 被引量:1
  • 9Todaro M, D'Asaro M, Caccamo N, et al. Efficient killing of hu- man colon cancer stem cells by gammadelta T lymphocytes [ J ]. J Immunol,2009,182 ( 11 ) :7287 - 96. 被引量:1
  • 10Dokouhaki P, Schuh N W, Joe B, et al. NKG2D regulates pro- duction of soluble TRAIL by ex vivo expanded human 3^st T cells [ J]. Eur J Immunol, 2013,43 (12) :3175 - 82. 被引量:1

二级参考文献12

  • 1徐刚,王兴鹏,赵国旗,吴恺,赵崧.塞来昔布对胰腺癌的放疗增敏作用及其机制研究[J].中华消化杂志,2006,26(11):753-757. 被引量:7
  • 2Merims S,Li X,Joe B. Anti-leukemia effect of ex vivo expanded DNT cells from AML patients:a potential novel autologous T-cell adoptive immunotherapy[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,2011,(09):1415-1422. 被引量:1
  • 3Dokouhaki P,Han M,Joe B. Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells:A new approach[J].Cancer Letters,2010,(01):126-136. 被引量:1
  • 4Ford M S,Chen W,Wong S. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development[J].European Journal of Immunology,2007,(08):2234-2241.doi:10.1002/eji.200636991. 被引量:1
  • 5Ford McIntyre M S,Young K J,Gao J. Cutting edge:in vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression[J].Journal of Immunology,2008,(04):2271-2275. 被引量:1
  • 6Young K J,Kay L S,Phillips M J. Antitumor activity mediated by double-negative T cells[J].Cancer Research,2003,(22):8014-8021. 被引量:1
  • 7Zhang Z X,Yang L,Young K J. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression[J].Nature Medicine,2000,(07):782-789. 被引量:1
  • 8Khan Q,Penninger J M,Yang L. Regulation of apoptosis in mature alphabeta CD-4CD-8 antigen specific suppressor T cell clones[J].Journal of Immunology,1999,(10):5860-5867. 被引量:1
  • 9Voelkl S,Gary R,Mackensen A. Characterization of the immunoregulatory function of human TCR-αβ+CD-4 CD-8 double-negative T cells[J].European Journal of Immunology,2011,(03):739-748. 被引量:1
  • 10Wang L,Chen W,Xie X. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer[J].Experimental Oncology,2008,(01):42-51. 被引量:1

共引文献1

同被引文献56

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部